Citation Impact
Citing Papers
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
2018
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
2009 StandoutScience
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Gastric cancer
2016 Standout
Clinical and histopathological evaluation of 13 cases of adenocarcinoma in aged rhesus macaques (Macaca mulatta)
2002
Epidemiology of upper gastrointestinal malignancies
2004
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
After gastritis – an imaginary journey into a Helicobacter‐free world
2002
The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis
2007
Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis
2015
Functional Gastroduodenal Disorders
2006 Standout
Inflammation, atrophy, and gastric cancer
2007
Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha,beta-unsaturated carbonyl group is a prerequisite
2002
The time to eradicate gastric cancer is now: Figure 1
2005
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique
2005
H. pylori infection and the development of gastric cancer
2002
Gastric mucosa: long-term outcome after cure ofHelicobacter pylori infection
2002
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype
2014
Helicobacter pylori and gastric diseases
1998
Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa
2001
Cost‐Effectiveness of Eradication of Helicobacter pylori in Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer
2009
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication
2004
Effect of early eradication on Helicobacter pylori‐related gastric carcinogenesis in Mongolian gerbils
2003
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis
2002
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
2000
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
2000
Asia–Pacific consensus guidelines on gastric cancer prevention
2008
Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction
2001
Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for prevention
2010
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer
2017
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis
2009
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry
2000
The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease
2005
Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia
2004
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases
2007
Host factors are important in determining clinical outcomes of Helicobacter pylori infection
2006
Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review
2009
Long-term pretreatment with proton pump inhibitor andHelicobacter pylorieradication rates
2014
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Polymorphism of interleukin-1β affects the eradication rates of Helicobacter pylori by triple therapy
2004
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Acid suppression and gastri atrophy: sifting fact from fiction
1998
The mechanisms for nitration and nitrotyrosine formationin vitroandin vivo: Impact of diet
2001
Long‐term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy
2003
Review article: Helicobacter pylori eradication for the prevention of gastric cancer
2007
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Gastric cancer
2020 Standout
Helicobacter pyloriInfection
2002 Standout
Histological changes of gastric mucosa afterHelicobacter pylorieradication: A systematic review and meta-analysis
2014
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
2001 Standout
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
The Effect of Helicobacter pylori Eradication on Reducing the Incidence of Gastric Cancer
2008
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis
2016
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin
2001
The cost‐effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial
2002
SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/CABG—trial design
1999
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
2010
Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance
2014
Cancer as an evolutionary and ecological process
2006 Standout
Helicobacter pylorieradication for preventing gastric cancer
2014
Potential Role of CagA in the Inhibition of T Cell Reactivity in Helicobacter pylori Infections
2000
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
2013
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Effect of Helicobacter Pylori Eradication on Subsequent Development of Cancer after Endoscopic Resection of Early Gastric Cancer in Japan
2000
Oxidative Stress and p53 Mutations in the Carcinogenesis of Iron Overload-Associated Hepatocellular Carcinoma
2001
Selective Nitration of Histone Tyrosine Residues in Vivo in Mutatect Tumors
2002
Helicobacter pylori and gastrointestinal tract adenocarcinomas
2002
The pros, cons, and many unknowns of probiotics
2019 Standout
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
The human microbiome: at the interface of health and disease
2012 Standout
Implications of Inducible Nitric Oxide Synthase Expression and Enzyme Activity
2000
Cardiogenic Shock
1999
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
2008
Helicobacter pylori Urease Suppresses Bactericidal Activity of Peroxynitrite via Carbon Dioxide Production
2000
The chemistry of zerumbone. Part 5: Structural transformation of the dimethylamine derivatives
2003 StandoutNobel
Improvement in Atrophic Gastritis and Intestinal Metaplasia in Patients in Whom Helicobacter pylori Was Eradicated
2001
A Conventional Beagle Dog Model for Acute and Chronic Infection withHelicobacter pylori
1999
Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation
2005
Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life
2006 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
2000
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.
2000
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Diagnosis of Helicobacter pylori Infection in Patients with Atrophic Gastritis: Comparison of Histology, 13C-Urea Breath Test, and Serology
2000
Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method"
2011
Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring
1999
Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans
2016
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Seroprevalence of cytotoxin‐associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in South China
1999
Epidemiology of gastric cancer
2006 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Works of K Sumii being referenced
Gastric corpus IL‐8 concentration and neutrophil infiltration in duodenal ulcer patients
1997
Carcinoembryonic Antigen Staining Patterns at the Invasive Tumor Margin Predict the Malignant Potential of Colorectal Carcinoma
1994
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
1997
Efficacy of percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction complicated by cardiogenic shock.
1992
Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients.
1999